The Indian pharma market, currently valued at around USD 55 billion, is projected to expand 2.2 to 2.4 times over the next ...
Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the ...
Oil India Ltd. key Products/Revenue Segments include Oil Crude, Gas Natural, Income From Transportation Services, Renewable Energy System, Condensate for the year ending 31-Mar-2024.For the quarter ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results